H2N2 influenza virus was the causative agent of an influenza pandemic known as Asian flu, which started in 1957. More than one million deaths were reported worldwide. However, H2 influenza viruses have not been detected in the human population since 1968 in replacement of another pandemic influenza caused by H3N2 influenza viruses. In contrast, H2 avian influenza viruses have been continuously circulating in wild aquatic and sporadically isolated from domestic birds around the world [6, 16, 17, 24, 28, 29] . In addition, H2N3 influenza viruses were isolated from pigs in 2006 in Missouri, U.S.A. [19] . These facts suggest that avian H2 influenza viruses may occasionally transmit to pigs and can be re-introduced into the human population in the future. Such an event could result in a pandemic because of the lack of acquired immunity against H2 influenza viruses in the current human population [27] . Therefore, vaccines against H2 influenza viruses are needed to prepare for a future human pandemic [20] .
The HA genes of H2 influenza viruses are phylogenetically divided into North American and Eurasian lineages [26] . The H2N2 influenza viruses that caused Asian flu belong to the Eurasian lineage and the H2N3 influenza viruses that were isolated from pigs in 2006 belong to the North American lineage. The avian H2 influenza virus A/black duck/New Jersey/1580/1978 (H2N3) antigenically cross-reacts with H2 influenza viruses isolated from humans and birds before 1991 [5, 14] . The H2N3 influenza viruses isolated from pigs show antigenic cross-reactivity with North American and Eurasian H2 avian influenza viruses [13] . However, information regarding the H2 influenza viruses recently isolated in Asia, particularly on the antigenicity of such viruses is limited. To prepare in case of H2 influenza virus transmission to the human population from animals, the characterization of genetic and antigenic properties of recent isolates, including viruses recently isolated from wild bird in Asia is greatly needed. Since 1996, we have conducted intensive surveillance of avian influenza in wild waterfowl in Hokkaido, Japan and Mongolia to monitor viruses that are maintained in the nesting lakes in Siberia and spread southward along with their migration in autumn. We reported the isolation of influenza viruses of various subtypes including H2 influenza viruses [7, 10, 29] . All viruses isolated in the surveillance study are stored in our influenza virus library (http://virusdb.czc.hokudai.ac.jp/). Previous studies demonstrated that cold-adapted live vaccines generated by human and avian H2 influenza viruses induce effective immunity against challenge using parental strains in mouse and ferret models [2, 3] . However, studies on the preparation of inactivated vaccine against H2 influenza are still limited. The aim of the present study is to evaluate the efficacy of an inactivated whole virus particle vaccine prepared from viruses recently isolated from wild birds in Asia based on its antigenicity, immunogenicity, and protective effects against challenge with swine H2 influenza virus in mice. (Table 1) were isolated from fecal samples of migratory ducks in our surveillance study [7, 10] . All viruses used in the present study were propagated in 10-day-old embryonated chicken eggs at 35°C for 48 hr, and infectious allantoic fluids were stored at −80°C until use. Madin-Darby canine kidney (MDCK) cells were grown in minimum essential medium (MEM) (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% inactivated calf serum and antibiotics and were used for titration of viral infectivity.
MATERIALS AND METHODS

Viruses and cells
Sequencing and phylogenetic analysis
Viral RNA was extracted from the allantoic fluids of embryonated chicken eggs using TRIzol LS Reagent (Life Technologies, Carlsbad, CA, U.S.A.) and reverse-transcribed with the Uni 12 primer (5′-AGCAAAAGCAGG-3′) and M-MLV Reverse Transcriptase (Life Technologies) [8] . The full-length HA gene segment was amplified by polymerase chain reaction (PCR) using Ex-Taq (TaKaRa, Shiga, Japan) and gene-specific primer sets [8] . Direct sequencing of each gene segment was performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies) and an auto-sequencer 3500 Genetic Analyzer (Life Technologies). Sequencing data were analyzed and aligned using Clustal W using GENETYX ® Network version 12 (Genetyx Co., Tokyo, Japan). The nucleotide sequences were phylogenetically analyzed by the maximum-likelihood (ML) method using MEGA 6.0 software (http://www.megasoftware.net/). Sequence data for H2 HA genes were compared with reference sequences selected and obtained from GenBank/EMBL/DDBJ.
Antigenic analysis
To analyze the antigenic properties of H2 influenza viruses, the hemagglutination inhibition (HI) test was performed using hyperimmunized chicken antisera against 7 representative strains of H2 viruses. Twenty-five microliters of 8 hemagglutination units of the test virus was added to 25 µl of 2-fold dilutions of each antiserum in PBS and incubated at room temperature for 30 min. After the incubation, 50 µl of 0.5% chicken red blood cells in PBS was added and incubated at room temperature for 30 min. HI titers were expressed as the reciprocal of the highest serum dilution showing complete inhibition of hemagglutination. 
Vaccine preparation
The selected vaccine strain, A/duck/Hokkaido/162/2013 (H2N1), and the challenge strain, A/swine/Missouri/2124514/2006 (H2N3), were inoculated into the allantoic cavities of 10-day-old embryonated chicken eggs and propagated at 35°C for 48 hr. The viruses in the allantoic fluids were purified by differential centrifugation and sedimentation through a sucrose gradient modified from Kida et al [15] . Briefly, allantoic fluids were ultracentrifuged and pellets were layered onto 10 to 50% sucrose density gradient and ultracentrifuged. The fractions containing viruses were collected based on the sucrose concentration, hemagglutination titer, and protein concentration. Whole virus particles were pelleted from the sucrose fractions by ultracentrifugation and suspended in a small volume of PBS. The purified viruses were inactivated by incubation in 0.1% formalin at 4°C for 7 days. Virus inactivation was confirmed by inoculation of the formalin-treated samples into embryonated chicken eggs. The total protein concentration was measured using the BCA Protein Assay Reagent (Thermo Fisher Scientific, Waltham, MA, U.S.A.). Each viral protein in the vaccine was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and the relative amounts of the hemagglutinin (HA) protein were assumed as a ratio of the HA protein in the total protein using ImageJ (http://rsb. info.nih.gov/ij/index.html). 
Potency test of vaccines in mice
Virus titration
Ten-fold dilutions of virus samples or mice lung homogenates were inoculated onto confluent monolayers of MDCK cells and incubated at 35°C for 1 hr. Unbound viruses were removed and the cells were washed with PBS. The cells were subsequently overlaid with MEM containing 5 µg/ml acetylated trypsin (Sigma-Aldrich, St. Louis, MO, U.S.A.). Titers were determined as the product of the reciprocal value of the highest virus dilution showing 50% of the cytopathic effects after 72 hr incubation and expressed as TCID 50 .
Serum neutralization test
Serum neutralizing antibody titers were measured according to the method of Sakabe et al [25] . Briefly, test sera and 100 TCID 50 of A/swine/Missouri/2124514/2006 (H2N3) or vaccine strain virus were mixed and incubated for 1 hr at room temperature. The mixture was inoculated onto MDCK cells and incubated at 35°C for 1 hr. Unbound viruses were removed and the cells were washed with PBS. The cells were subsequently incubated in MEM containing 5 µg/ml acetylated trypsin (Sigma-Aldrich). Cytopathic effects were observed after 72 hr incubation and neutralizing antibody titers were determined as the reciprocal of the serum dilution yielding 50% inhibition of the cytopathic effects.
Ethics statement
Animal experiments were authorized by the Institutional Animal Care and Use Committee of the Graduate School of Veterinary Medicine, Hokkaido University (approved numbers: 13-0104, 15-0063), and all experiments were performed according to the guidelines of this committee.
RESULTS
Genetic analysis of H2 influenza viruses
Nucleotide sequences of HA genes of the H2 viruses in the influenza virus library were determined and phylogenetically analyzed along with reference sequences available in the public database (Table 1 and Fig. 1 ). Nucleotide sequences of viruses isolated in Hokkaido in 2013 showed high similarity (99.7-100%) and A/duck/Hokkaido/162/2013 (H2N1) was selected as a representative strain. Based on the results of phylogenetic analysis, the H2 HA genes were classified into Eurasian and North American lineages as the previous study described [26] . The Eurasian linage included viruses isolated in Asia, Europe, and Alaska, while the North American linage included viruses mainly isolated in North America. Viruses belonging to the Eurasian linage were further divided into 4 clusters. Viruses in cluster 1 were avian influenza viruses isolated before the 1980's. Human H2N2 influenza viruses formed a single cluster, cluster 2. This study revealed that avian H2 influenza viruses isolated in Japan in the 1980's doi: 10.1292/jvms. (represented by A/pintail/Shimane/1086/1981 (H2N3) in the phylogenetic tree) belonged to cluster 3, along with European isolates around the same period. Recent isolates from avian species in European and Asian countries formed cluster 4. These results clearly demonstrate that H2 influenza viruses recently circulating among birds are genetically distant from human H2N2 viruses. Swine H2N3 viruses belong to the North American lineage and no avian viruses recently isolated in the East Asia region are genetically close to the swine H2N3 viruses.
Antigenic analysis of H2 influenza viruses
Seven H2 influenza virus strains representatives of each genetic cluster were selected and antigenically analyzed by HI test (Table 2) 
Potency test of the vaccine against H2 influenza virus in mice
Based on the results of antigenic analysis, all viruses tested in the present study showed cross-reactivity with viruses belonging to the other genetic groups. Thus, the most recent isolate at the beginning of this study, A/duck/Hokkaido/162/2013 (H2N1), was assumed to be vaccine candidates and used in following examinations. Neutralizing antibody titers of sera collected from mice immunized once with either A/duck/Hokkaido/162/2013 (H2N1) or A/swine/Missouri/2124514/2006 (H2N3) were low (Table 3) . In contrast, the neutralizing antibody titers of mice sera injected twice with either vaccines were reached up to 1:320 against the homologous virus (Table 4 
DISCUSSION
Vaccination is the most effective control measure for human pandemic influenza and the preparation of vaccines for future H2 influenza pandemics is necessary [20] . Our results demonstrated that an inactivated whole virus particle vaccine prepared from recent avian H2 influenza virus, A/duck/Hokkaido/162/2013 (H2N1), is effective for use in future human pandemics. A/duck/ Hokkaido/162/2013 (H2N1) showed broad antigenic cross-reactivity and thus was selected as the vaccine candidate strain in this study [18] .
Our findings supported the effectiveness of inactivated whole virus particle vaccine against H2 influenza because avian H2 influenza viruses currently circulating among birds are also effective. Our inactivated vaccine prepared from A/ duck/Hokkaido/162/2013 (H2N1) required 2 rounds of vaccination to induce neutralizing antibodies in mice to A/swine/ Missouri/2124514/2006 (H2N3); thus, the dosage of vaccine and the most effective administration strategy should be considered to improve the efficacy of this vaccine.
We have established an influenza virus library for storing various influenza viruses for use as seed for vaccines. Influenza viruses of 144 combinations including 16 HA and 9 neuraminidase subtypes isolated from animals or generated in our laboratory have been stored in the library. Our previous studies revealed that whole virus particle vaccines prepared from this library induce effective immunity against infections with H1, H5, H6, H7 and H9 influenza viruses in mice and macaque models [4, 11, 12, [21] [22] [23] . In the present study, the vaccine candidate strain against H2 influenza selected from the influenza library is shown to be potentially useful for a future H2 influenza pandemic. Our annual influenza surveillance in wild birds in Japan and Mongolia effectively monitors virus circulation in wild birds in East Asian countries and also provides a variety of influenza viruses [7, 29] . Thus, our library is updated each season, providing specimens from which we might gain novel information about the antigenicity of H2 influenza viruses circulating in wild birds in East Asian countries.
In further studies, monitoring of introduction of H2 influenza virus into pig population and emergence of mammalian adapted H2 influenza viruses is important for early response to a human pandemic. In addition, the continuous surveillance and antigenic analysis of H2 influenza viruses in both wild birds and poultry are necessary to prepare for a future pandemic and allow for rapid vaccine preparation.
